LITTLE FALLS, N.J., Sept. 23, 2019 /PRNewswire/ -- Cantel Medical Corp. (NYSE: CMD) today announced financial results for its fourth quarter ended July 31, 2019.

SAN JOSE, Calif., Sept. 23, 2019 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system to fight cancer, today a

WARSAW, Ind., Sept. 23, 2019 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its third quarter sales and earnings conference call will be broadcast over the Internet on Tuesday, November 5, 2019, at 8:30 a.m. Eastern Time.  A news release detailing the quarterly results will

SHANGHAI, Sept. 23, 2019 /PRNewswire/ -- I-Mab Biopharma ("I-Mab"), a China and U.S.-based clinical stage biopharmaceutical company exclusively focusing on the discovery and development of potential first-in-class and best-in-class biologics in immuno-oncology and autoimmune diseases, today announced that it has entered into a clinical re

BRENTWOOD, Tenn., Sept. 23, 2019 /PRNewswire/ -- Brookdale Senior Living Inc. today announced it has won a Best Practices award from Health Ethics Trust (the "Trust") for its compliance education program.

INDIANAPOLIS, Sept. 23, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced data from a number of studies across the company's oncology product portfolio will be presented at the European Society for Medical Oncology (ESMO) 2019 Congress in Barcelona, Spain, September 27 - October 1, 2019

STAINES-UPON-THAMES, United Kingdom, Sept. 23, 2019 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, today an

TORONTO, Sept. 23, 2019 /PRNewswire/ - Baylis Medical announced today the successful first MitraClip™ procedure performed using the VersaCross™ Transseptal Solution. The VersaCross solution is the world's first all-in-one left-heart access device featuring an atraumatic RF-tipped pigtail wire. The device is designed to achieve left-heart access with controlle

MEMPHIS, Tenn., Sept. 23, 2019 /PRNewswire/ -- West Cancer Center is pleased to announce they have been designated as the first center in the country approved to prescribe NovoTTF-100L for the treatment of malignant pleural mesothelioma (MPM). Experts at West Cancer Center are now certified to prescribe this wearable and portable medical device, the first FDA-approv

SHANGHAI, Sept. 23, 2019 /PRNewswire/ -- CARsgen Therapeutics Inc., a clinical-stage biopharmaceutical company today announced the European Medicines Agency (EMA) has granted PRIority MEdicines (PRIME) eligibility to its investigational CAR-T cell therapy fully human anti-BCMA (B Cell Maturation Antigen) autologous chimeric antigen receptor (CAR) T Cells (ct053) for